Angcon, Noveln .

HRN: 22-47-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CEFUROXIME 500MG (TAB)
01/09/2023
01/15/2023
PO
1 Tab
BID
UTI
Waiting Final Action 
01/09/2023
CEFUROXIME 750MG (VIAL)
01/09/2023
01/16/2023
IV
750mg
Q8H
UTI
01/12/2023
CEFUROXIME 1.5GM (VIAL)
01/12/2023
01/19/2023
UTI
1.5g
Q8
Uti
Waiting Final Action 
01/13/2023
CEFIXIME 200MG (CAP)
01/13/2023
01/17/2023
ORAL
200mg
BID
UTI
Waiting Final Action 
04/24/2023
CEFTRIAXONE 1G (VIAL)
04/24/2023
04/26/2023
IV
2g
Od
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: